表紙
市場調查報告書

冠狀動脈支架的全球市場:市場規模,佔有率,趨勢分析 - 產品(傳統金屬支架,藥劑溶出性血管支架,生物吸收性血管sukyaforudo),各地區

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 374559
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
冠狀動脈支架的全球市場:市場規模,佔有率,趨勢分析 - 產品(傳統金屬支架,藥劑溶出性血管支架,生物吸收性血管sukyaforudo),各地區 Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027
出版日期: 2020年03月16日內容資訊: 英文 110 Pages
簡介

全球冠狀動脈支架市場在2020年∼2027年間,預測將以4.7%的年複合成長率發展,到2027年成長到113億美元的規模。預計微創手術和經皮冠狀動脈介入治療(PIC)的採用增加,老年人口的增加,第2代藥物釋放型性支架(DES)的技術進步,不含聚合物的生物分解性藥劑溶出性血管支架(DES)的開發等促進這個市場成長。

本報告提供全球冠狀動脈支架市場調查,市場概要,各產品、各地區的市場規模的變化與預測,市場佔有率,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查手法

  • 調查手法
  • 資訊採購
  • 資料分析
  • 市場形成與檢驗
  • 模式詳細內容
  • 2次資訊來源的清單
  • 1次資訊來源的清單
  • 簡稱
  • 調查目的

第2章 摘要整理

  • 市場概述

第3章 產業預測

  • 市場區隔
  • 市場系統預測
  • 市場動態
    • 成長要素分析
    • 阻礙因素分析
    • 課題
  • 滲透與成長預測製圖
  • 用戶觀點分析
    • 消費行為分析
    • 市場影響者分析
  • 價格分析
  • 技術概要
  • 法律規範
  • 產品平台/臨床試驗分析
  • 研究開發費分析
  • 研究開發費分析
  • 產品的回收
  • 商務環境分析工具
    • SWOT分析
    • 波特的五力分析

第4章 競爭情形

  • 參與企業的區分
  • 競爭儀表板
  • 創新企業
  • 公開公司
  • 業者情勢

第5章 冠狀動脈支架市場分析:各產品

  • 市場趨勢分析:各產品
  • 傳統金屬支架
  • 藥物釋放型性支架
  • 生物吸收性血管支架

第6章 冠狀動脈支架市場分析:各地區

  • 市場佔有率:各地區(成果值、預測值)
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 企業簡介

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • MicroPort Scientific Corporation
  • C. R. Bard, Inc.
  • Cook Medical
目錄
Product Code: GVR-1-68038-106-1

The global coronary stents market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 4.7%, according to a new report by Grand View Research, Inc. Increasing adoption of minimally invasive surgeries and percutaneous coronary intervention (PIC) procedures is expected to drive the market for coronary stents in the coming years. Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period. Technological advancement in 2nd generation drug eluting stents (DES) is further fueling the growth. Development of biodegradable and polymer free DES in order to increase patient compliance is expected to drive the market over the coming years.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare and Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service provider. From January 2020, Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in ambulatory surgical center (ASC), which is expected to boost market revenue over the forecast period.

Further key findings from the report suggest:

In terms of revenue, the DES dominated the product segment as of 2019. New product launches and technological advancements in 2nd gen DES are acting as the driving factor for this segment

Prices for the first-generation BVS (Bioresorbable Vascular Scaffold) are much high as compared to existing BMS (Bare Metal Stent) and DES. Due to its safety concern and high hospitalization rates, doctors are not preferring BRS over DES. Moreover, high crossing profile and bulky struts are factors majorly impeding the BRS market

Asia Pacific is expected to exhibit the highest growth rate over the forecast period. Increase in disposable income and growing incidence of heart diseases will fuel market growth in the coming years

Some of the key companies present in the coronary stent market are Medtronic, Abbott, Boston Scientific, Terumo Corporation, Biotronik, and Microport Corporation

With USD 2.3 billion R&D expenditure in 2018, Abbott is anticipated to provide with technologically advanced second generation DES and may be BVS in near future.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research Methodology
  • 1.2 Information Procurement
    • 1.2.1 Purchased Database:
    • 1.2.2 GVR's Internal Database
    • 1.2.3 Secondary Sources
    • 1.2.4 Primary Research:
    • 1.2.5 Details Of Primary Research
  • 1.3 Information or Data Analysis
    • 1.3.1 Data Analysis Models
  • 1.4 Market Formulation & Validation
  • 1.5 Model Details
    • 1.5.1 Commodity Workflow Analysis (Model 1)
  • 1.6 List of Secondary Sources
  • 1.7 List of Primary Sources
  • 1.8 Abbreviations
  • 1.9 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Industry Outlook

  • 3.1 Market Segmentation
  • 3.2 Market Lineage Outlook
    • 3.2.1 Parent Market Analysis
    • 3.2.2 Ancillary Market Analysis
  • 3.3 Market Variable Analysis
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising burden of Cardiovascular Diseases (CVDs)
      • 3.3.1.2 Government initiatives to reduce cost of coronary stents
      • 3.3.1.3 Advancements in stenting technologies
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Stringent regulation and approval
      • 3.3.2.2 Product recall and failure
    • 3.3.3 Industry Chanllenges
      • 3.3.3.1 Risk associated with coronary stent post procedure
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer Behavior Analysis
    • 3.5.2 Market Influencer Analysis
  • 3.6 Pricing Analysis
  • 3.7 Technology Overview
  • 3.8 Regulatory Framework
    • 3.8.1 Regulatory Landscape
    • 3.8.2 Reimbursement Framework
      • 3.8.2.1 CPT Coding implications
      • 3.8.2.2 HCPCS Coding implications
    • 3.8.3 Cms New Reimbursement Policy For Pci
  • 3.9 Product Pipeline/Clinical Trial Analysis
  • 3.10 R&D Expenditure Analysis
  • 3.11 Estimated R&D Expenditure On Various Types Of Stents (2014 - 2019)
  • 3.12 Product Recalls
  • 3.13 Business Environment Analysis tools
    • 3.13.1 Swot Analysis, By Pest
    • 3.13.2 Porter's Five Forces Analysis

Chapter 4 Coronary Stents Market: Competitive Analysis

  • 4.1 Market Participation Categorization
  • 4.2 Competitive Dashboard Analysis
  • 4.3 Innovators
  • 4.4 Recent Innovations
  • 4.5 Public Companies
    • 4.5.1 Company Market Share Analysis
    • 4.5.2 Company Market Position Analysis
    • 4.5.3 Heat Map Analysis
  • 4.6 Vendor Landscape
    • 4.6.1 List Of Coronary Stent Providers

Chapter 5 Product Segment Analysis

  • 5.1 Coronary Stents Market: Product Movement Analysis
  • 5.2 Bare Metal Stents
    • 5.2.1 Bare Metal Stents Market, 2016 - 2027 (USD Million)
  • 5.3 Drug Eluting Stents
    • 5.3.1 Drug Eluting Stents Market, 2016 - 2027 (USD Million)
    • 5.3.2 Biodegradable Drug Eluting Stents
      • 5.3.2.1 biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
    • 5.3.3 Non-Biodegradable Drug Eluting Stents
      • 5.3.3.1 non-biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • 5.4 Bioresorbable Vascular Scaffolds
    • 5.4.1 Bioresorbable Vascular Scaffolds Market, 2016 - 2027 (USD Million)

Chapter 6 Coronary Stents Market: Regional Estimates & Trend Analysis, by Product

  • 6.1 Coronary Stents Market Share by Region, 2019 & 2027
  • 6.2 North America
    • 6.2.1 North America Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. Coronary Stents market, 2016 - 2027 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada Coronary Stents market, 2016 - 2027 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.5 Italy
      • 6.3.5.1 Italy coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.6 Spain
      • 6.3.6.1 Spain coronary stents market, 2016 - 2027 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.4.2 Japan
      • 6.4.2.1 Japan coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.3 China
      • 6.4.3.1 China coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.4 India
      • 6.4.4.1 India coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia coronary stents market, 2016 - 2027 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil coronary stents market, 2016 - 2027 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico coronary stents market, 2016 - 2027 (USD Million)
    • 6.5.4 Argentina
      • 6.5.4.1 Argentina coronary stents market, 2016 - 2027 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa coronary stents market, 2016 - 2027 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia coronary stents market, 2016 - 2027 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE coronary stents market, 2016 - 2027 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Company Overview
    • 7.1.2 Financial Performance
    • 7.1.3 Product Benchmarking
    • 7.1.4 Strategic Initiatives
  • 7.2 Medtronic
    • 7.2.1 Company Overview
    • 7.2.2 Financial Performance
    • 7.2.3 Product Benchmarking
    • 7.2.4 Strategic Initiatives
  • 7.3 Boston Scientific Corporation
    • 7.3.1 Company Overview
    • 7.3.2 Financial Performance
    • 7.3.3 Product Benchmarking
    • 7.3.4 Strategic Initiatives
  • 7.4 Terumo Corporation
    • 7.4.1 Company Overview
    • 7.4.2 Financial Performance
    • 7.4.3 Product Benchmarking
    • 7.4.4 Strategic Initiatives
  • 7.5 B Braun Melsungen AG
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6 Biotronik
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 Stentys SA
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
    • 7.7.4 Strategic Initiatives
  • 7.8 MicroPort Scientific Corporation
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 C. R. Bard, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Performance
    • 7.9.3 Product Benchmarking
    • 7.9.4 Strategic Initiatives
  • 7.10 Cook Medical
    • 7.10.1 Company Overview
    • 7.10.2 Product Benchmarking
    • 7.10.3 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 CPT Coding
  • Table 4 HCPCS Coding
  • Table 5 CMS new reimbursement coding for PCI
  • Table 6 Product pipeline/clinical stage
  • Table 7 R&D expenditure analysis of public companies (2018)
  • Table 8 Leading market players anticipated to witness highest growth
  • Table 9 List of coronary stents service providers
  • Table 10 Leading cause of death in elderly population in the U.S. in 2019
  • Table 11 North America Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 12 U.S. Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 13 Canada Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 14 Europe Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 15 U.K. Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 16 Germany Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 17 France Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 18 Italy Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 19 Spain Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 20 Asia Pacific Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 21 Japan Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 22 China Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 23 India Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 24 South Korea Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 25 Australia Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 26 Latin America Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 27 Brazil Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 28 Mexico Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 29 Argentina Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 30 MEA Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 31 South Africa Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 32 Saudi Arabia Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 33 UAE Coronary Stents market, by product, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity workflow analysis
  • Fig. 9 Market summary
  • Fig. 10 Coronary Stents market segmentation
  • Fig. 11 Parent Market Analysis
  • Fig. 12 Ancillary Market Analysis
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Incidence of CVDs in the U.S. in 2019
  • Fig. 15 Stent type and volume after price reduction in 2018
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Penetration & growth prospect mapping
  • Fig. 18 Consumer behavior analysis
  • Fig. 19 Market influencer analysis
  • Fig. 20 Coronary Stents technology timeline
  • Fig. 21 R&D expenditure analysis (2014 - 2019)
  • Fig. 22 SWOT analysis, by PEST
  • Fig. 23 Porter's Five Forces Analysis
  • Fig. 24 Market participant categorization
  • Fig. 25 Competitive dashboard analysis
  • Fig. 26 Company market share analysis
  • Fig. 27 Company market position analysis
  • Fig. 28 Heat map analysis
  • Fig. 29 Coronary stents market product outlook: Key takeaways
  • Fig. 30 Coronary stents market: Product movement analysis
  • Fig. 31 Bare Metal Stents market, 2016 - 2027 (USD Million)
  • Fig. 32 Drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 33 Biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 34 Non-biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 35 Bioresorbable vascular scaffolds market, 2016 - 2027 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Regional Outlook, 2019 & 2027
  • Fig. 38 North America coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 39 U.S. coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 40 Canada Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 41 Europe Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 42 U.K. coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 43 Germany coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 44 France coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 45 Number of individuals suffering from heart disease, 2010 - 2017
  • Fig. 46 Italy coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 47 Spain coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 48 Asia Pacific Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 49 Japan coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 50 China coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 51 India coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 52 South Korea coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 53 Australia coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 54 Latin America coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 55 Brazil coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 56 Mexico coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 57 Argentina coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 58 MEA coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 59 South Africa coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 60 Saudi Arabia coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 61 UAE coronary stents market, 2016 - 2027 (USD Million)